Indivior to Participate in Investor Events

RNS Number : 4945Y

Indivior PLC

06 September 2022

 

Indivior To Participate In Upcoming Investor Events

Slough, UK, and Richmond, VA, September 6, 2022 - Indivior PLC (LON: INDV) today announced that it will participate in the following investor events:

· Morgan Stanley 20^th Annual Global Healthcare Conference - New York

Mark Crossley, Chief Executive Officer (CEO), will host 1x1/group meetings on Monday, September 12^th and participate in a fireside chat at 8:10 a.m. US EST.  Investors can contact their Morgan Stanley representative to schedule a meeting.  The fireside chat can be viewed using the following weblink: Indivior PLC - 1566921 (webcasts.com)

· Bank of America Global Healthcare Conference 2022 - London

Mark Crossley, CEO, will host 1x1/group meetings on Thursday and Friday, September 15^th and 16^th and host a presentation September 16^th at 13:20 (BST) (8:20 a.m. US EST).  Investors can contact their Bank of America representative to schedule a meeting.  The presentation will be available at www.indivior.com and can also be viewed using the following webcast link: Indivior PLC - BOA Webcast

· Jefferies Global Healthcare Fireside Chat Series - Virtual

Mark Crossley, CEO, will participate in a fireside chat on Wednesday, September 21^st at 16:30 (BST) (11:30 a.m. US EST).  The fireside chat can be viewed using the following weblink: Webinar Registration - Zoom

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs approximately 1,000 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: [phone] or [e-mail]

Tim Owens

Director, Investor Relations

Tel: [phone] or [e-mail]

###

 

END

 

 

MSCFLFSEAFIRIIF